2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
Jacqueline Cloos, Peter J.M. Valk, Christian Thiede, Konstanze Döhner et autres
56 citationsBlood
Gert J. Ossenkoppele
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
525Publications signalées
34624Citations signalées
9Affiliations récentes
Institutions déclarées
Domaines associés
Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia researchChronic Lymphocytic Leukemia Research
Publications récentes
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia
Lukas H. Haaksma, Raffaele Palmieri, Tom Reuvekamp, Jesse M. Tettero et autres
1 citationLeukemia
Updated response and safety analyses from a Phase 1 study of ivosidenib combined with intensive chemotherapy in patients with newly diagnosed (ND) Acute Myeloid Leukemia with isocitrate dehydrogenase (IDH)1 mutation
Eytan M. Stein, Courtney D. DiNardo, Amir Fathi, Alice S. Mims et autres
2 citationsBlood
Autologous stem cell transplantation versus consolidation chemotherapy as post-remission treatment in newly diagnosed favorable and intermediate risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials
Dimitrios Kotsos, Carin Hazenberg, Thomas Pabst, Patrycja Gradowska et autres
0 citationsHemaSphere
Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia
Amin T. Turki, Daniele Dall’Olio, Luciana Carota, Stefano Polizzi et autres
0 citationsBlood
The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncology
A. J. Smit, N Maas, Bronno van der Holt, Yvette van Norden et autres
1 citationHaematologica
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T‐cell therapy
Jort J. van der Schans, Paresh Vishwasrao, Renée Poels, Morgan Antti et autres
2 citationsHemaSphere
Comparability of external and internal control patients for the prospective randomized HOVON ‐103 trial in older AML patients
Sjoerd J. F. Hermans, Jurjen Versluis, Erik van Werkhoven, Yvette van Norden et autres
0 citationsBritish Journal of Haematology
A revised prognostic model for patients with acute myeloid leukemia and first relapse
N Maas, Dimitri Breems, Clara Klerk, Thomas Pabst et autres
2 citationsBlood Advances
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients
Lok Lam Ngai, Tom Reuvekamp, Diana Hanekamp, Fleur Janssen et autres
2 citationsHaematologica
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents
Tom Reuvekamp, Lok Lam Ngai, Daphne den Hartog, Jannemieke Carbaat‐Ham et autres
12 citationsLeukemia
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Adriano Venditti, Raffaele Palmieri, Luca Maurillo, Christoph Röllig et autres
29 citationsBlood Advances
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.